61F79587-1D51-7AC7-0FF3-79929730AA58	BB0DB1BA-B394-E1FD-7FAA-79929730AE11	0D898A33-8659-FE46-F868-79929730E186.4B7787C7-45FD-4D78-AF39-7995B86A8655	0D898A33-8659-FE46-F868-79929730E186.8EE37F4D-183E-D77D-E671-7995E491E525	0D898A33-8659-FE46-F868-79929730E186.7B7EA2A0-7306-4EF4-6A53-7996471DC2EA	832FECE1-219F-9481-BC19-799297309970	4DEC130C-07F0-6932-D6A9-799297306FCCcell-type	promoter-construct	molecular-fragment: molecule	molecular-fragment: fragment-start	molecular-fragment: fragment-end	primary-antibody	protein-concentration Cos-7	 Sos-1	E3b1-fragment	2	480	 Sos-1	 high Cos-7	 Sos-1	E3b1-fragment	2	330	 Sos-1	none Cos-7	 Sos-1	E3b1-fragment	331	480	 Sos-1	high Cos-7	 Sos-1	E3b1-fragment	371	480	 Sos-1	high Cos-7	 Sos-1	E3b1-fragment	398	480	 Sos-1	high Cos-7	 Sos-1	E3b1-fragment	331	424	 Sos-1	none Cos-7	 Sos-1	E3b1-fragment	416	480	 Sos-1	strong Cos-7	 Sos-1	E3b1-fragment	425	480	 Sos-1	none